Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Supplement Ingredient Suppliers Should Prepare For Food HACCP Regs

This article was originally published in The Tan Sheet

Executive Summary

The exemption Congress gave dietary supplement manufacturers from the hazard analysis and critical control points regulations for food products does not extend to ingredient suppliers, experts say.

You may also be interested in...

Supplement GMP Documentation Better, But Still No. 2 On FDA Observation List – AHPA

FDA revisits about a third of supplement manufacturing sites, with two-thirds coming within three years, says AHPA. Chief information analyst Merle Zimmermann says FDA increased focus on recordkeeping has resulted in an improvement and fewer problems reported since 2015

Health And Wellness Industry News: Court Slams FDA E-cigarette Delay, Neopac Launches US Production

A Maryland federal court says FDA acted illegally on e-cigarettes guidance; Deadline for FSMA Qualified Importer Program applications extended; FDA allows enforcement discretion for potassium chloride salt labeling; Swiss packaging firm Hoffmann Neopac opens US plant; and more news.

FDA's Tighter Targeting For GMP Inspections Still Leaves Consistency Gap

The number of facilities inspected for compliance with supplement GMP requirements is increasing annually as the agency meets targets set by FSMA, according to data the American Herbal Products Association presented during a webinar.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts